See Which Of The Latest 13F Filers Holds PFE

Aggregate analysis of 13F filings for the 06/30/2025 reporting period reveals that hedge funds collectively reduced their holdings in Pfizer Inc (PFE) by approximately 1.62%, or 1,458,359 shares, from 90,052,679 to 88,594,320 shares between Q1 and Q2 2025. This net divestment trend, observed across 1,488 funds despite the long-only nature of 13F disclosures, indicates a slight decrease in institutional long exposure to PFE.

Analysis

Analysis of 13F filings for the period ending June 30, 2025, indicates a modest net reduction in institutional holdings of Pfizer Inc. (PFE). Across a broad sample of 1,488 funds, aggregate share count decreased by 1.62%, a net divestment of 1,458,359 shares, bringing total holdings down to 88,594,320 from 90,052,679 in the prior quarter. This broad-based selling suggests a slight cooling in institutional sentiment. A smaller, more recent sample of 11 funds presented a mixed picture, with an equal number of funds increasing (5) and decreasing (5) their positions. This smaller cohort saw a net increase of 49,839 shares but a net market value decrease of $205,000, potentially reflecting a decline in PFE's share price during the holding period. It is crucial to acknowledge the limitation that these filings only disclose long positions, omitting any short sales or bearish options strategies that could provide a more complete view of a fund's overall thesis.

Key Decisions for Investors

• The 1.62% net reduction in institutional holdings is a noteworthy, albeit modest, negative signal that should be weighed against Pfizer's fundamental performance and upcoming catalysts.
• Investors should treat this fund flow data as a prompt for further due diligence, particularly by monitoring changes in short interest and analyst ratings to corroborate this potential shift in sentiment.
• Given that 13F filings do not capture short positions, a cautious approach is warranted; the data signals a slight decrease in long-only conviction rather than a definitive bearish institutional consensus.